High-Fiber/Low-Fat Diet for C. diff Infection Prevention in Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a high-fiber, low-fat diet can prevent the recurrence of C. difficile infections, a type of gut infection, in people with cancer. Participants will either follow this special diet or maintain their usual eating habits. The study seeks cancer patients who have recently experienced a C. difficile infection and currently consume a diet high in saturated fat and low in fiber. As an unphased trial, it offers a unique opportunity for patients to contribute to research that could enhance dietary recommendations for cancer patients.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this dietary intervention is safe for cancer patients?
Research has shown that a high-fiber diet can maintain gut health. This diet can lower certain bile acids that promote the growth of harmful bacteria like C. difficile. In contrast, animal studies have linked low-fiber, high-fat diets to a higher risk of infections.
Regarding safety, most people can adopt a high-fiber, low-fat diet without major issues. Significant side effects are not commonly reported with this dietary change, making it a safe option for reducing infection risk, including C. difficile, especially for cancer patients with weakened immune systems. While not a traditional "treatment" like medication, it is a lifestyle change with a strong safety record.12345Why are researchers excited about this trial?
Researchers are excited about the high-fiber/low-fat diet intervention for preventing C. diff infections in cancer patients because it offers a natural, dietary approach that could complement or even reduce the need for antibiotics, which are the standard treatment today. Unlike antibiotics, which target bacteria directly and can disrupt the gut microbiome, this diet aims to strengthen the microbiome by providing beneficial nutrients and promoting a balanced gut environment. By enhancing the body's natural defenses through nutrition, this method could offer a safer, sustainable option with fewer side effects, especially important for vulnerable cancer patients who are often at higher risk for infections.
What evidence suggests that a high-fiber/low-fat diet could be effective for preventing C. diff infection in cancer patients?
Research has shown that a high-fiber diet might lower the risk of several types of cancer, especially colon cancer. Out of 32 studies, 25 support this protective effect. Some studies also suggest that fiber could help with Clostridioides difficile (C. diff) infections, though results are mixed. In this trial, participants in one arm will follow a high-fiber/low-fat diet intervention, which might help prevent C. diff infections from recurring in cancer patients. Evidence suggests that dietary changes could benefit those at risk of these infections.15678
Who Is on the Research Team?
Catherine Lozupone
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for oncology patients aged 9 or older at Children's Hospital Colorado or the University of Colorado Hospital, diagnosed with acute leukemia or lymphoma and a first-time or recurrent C. difficile infection. Participants must be able to follow the study plan and have specific dietary habits based on a questionnaire.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a diet intervention or no diet intervention for 6 weeks. In the diet intervention arm, participants receive a diet higher in fiber and lower in fat, with weekly grocery support. In both arms, food consumption, weight, and stool samples are monitored weekly.
Follow-up
Participants are monitored for C. difficile infection recurrence and stool consistency for an additional period after the treatment phase.
What Are the Treatments Tested in This Trial?
Interventions
- High-Fiber/Low-Fat Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator